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INTRODUCTION 
Transient receptor potential (TRP) cation channels are emerging as important molecular 
elements of sensory transduction events (Clapham, 2003; Voets et al., 2005). TRP channels 
play key roles in nociception, photo-, chemo-, thermo- and mechano-osmotic transduction 
(Dhaka et al., 2006; Venkatachalam & Montell, 2007). The detection of mechanical stimuli is 
essential for basic physiological functions such as touch, hearing, myogenic vascular tone, 
muscle stretch, and volume regulation by the kidney (Hamill & Martinac, 2001; Kung, 2005). 
Several TRP channels are sensitive to various forms of mechanical stress, including the 
increase in membrane surface tension produced by osmotic swelling (Pedersen & Nilius, 
2007; Christensen & Corey, 2007; Raoux M et al., 2007). TRPV4 was the first TRP channel 
to be described as activated by osmotic cell swelling (Strotmann et al., 2000; Liedtke et al., 
2000). This activation is not due to direct stretch but is mediated by 5’,6’-epoxyeicosatrienoic 
acid (5’,6’-EET), a metabolite of arachidonic acid (Watanabe et al., 2003; Vriens et al., 
2004). TRPV2 is also activated by osmotic cell swelling (Muraki et al., 2003; Beech et al., 
2004) and responds to stretch in vascular smooth muscle cells although its mechanism of 
activation remains unclear. TRPM4 (Dietrich et al., 2006; Earley et al., 2004; Kraft & 
Harteneck, 2005; Inoue et al., 2006), and a long splice variant of TRPM3 (Grimm et al., 
2003) are also activated by hypotonic cell swelling. Among the TRPC family, TRPC1 and 
TRPC6 are activated by mechanically or osmotically induced membrane stretch (Maroto et 
al., 2005; Spassova et al., 2006), which led these authors to hypothesize a role of TRPC6 in 
the regulation of myogenic vascular tone. However, more recent reports have challenged the 
mechanical gating of TRPC6 and TRPC1 channels (Dietrich et al., 2007; Gottlieb et al., 2008; 
Sharif-Naeini et al., 2008). 
TRPC5 and its close homolog TRPC4 form group 4 of mammalian TRPC channels (Plant & 
Schaefer, 2003). TRPC5 is highly expressed in the central nervous system (Fowler et al., 
2007) and at lower levels in many other tissues such as gonads, lung, heart, adrenal gland, 
endothelium, kidney and vascular and gastric smooth muscle (Philipp et al., 1998; Okada et 
al., 1998; Riccio et al., 2002; Beech et al., 2004). TRPC5 channels can be turned on by 
activating receptors that couple to PLC (Schaefer et al., 2000; Putney, Jr., 2004). This 
activation is also dependent on Ca2+ (Okada et al., 1998; Schaefer et al., 2000). At present, 
there is very limited information on the physiological role of TRPC5 channels. In the brain, 
TRPC5 activity regulates neurite extension in the hippocampus by a mechanism involving 
recruitment of channels to the plasma membrane (Greka et al., 2003). The activity of TRPC5 
is also increased by extracellular acidity (Semtner et al., 2007) although further studies are 
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necessary to establish the role of changes in pH in the regulation of TRPC5 activity in native 
tissues. More recently, it was found that extracellular reduced thioredoxin (rTRX) activates 
TRPC5 channels (Xu et al., 2008). Elevated rTRX occurs in human joints affected by 
rheumatoid arthritis and its activity is correlated with disease severity (Maurice et al., 1999; 
Lemarechal et al., 2007). It has also been proposed that TRPC5 acts as a direct sensor of 
lysophospholipids (Flemming et al., 2006), suggesting that this channel exhibits sensitivity to 
the structure of the lipid bilayer. TRPC5 is also present in baroreceptors (Glazebrook et al., 
2005), the peripheral nerve endings involved in sensing arterial pressure, thus making the 
channel a potential candidate protein for osmo-mechanical transduction.  
In this work, we address the role of TRPC5 as a potential osmo-mechanical transducer 
channel. Our data demonstrate activation of TRPC5 by hypoosmotic and pressure induced 
membrane stretch. Moreover, hypoosmotic induced membrane stretch is blocked by GsMTx-
4, an inhibitor of stretch and mechanical activated ion channels (Suchyna et al., 2000; Park et 
al., 2008). Activation of TRPC5 by membrane stretch is independent of PLC signalling 
although it requires permissive levels of PIP2 in the plasma membrane. Our results reveal a 
novel activation pathway for TRPC5 channels. Moreover, prominent expression of this 
channel in trigeminal ganglion sensory neurones suggests a possible involvement of TRPC5 
in mammalian osmo-mechanosensory transduction.  
 
MATERIAL AND METHODS 
Bathing solutions and reagents 
We employed external solutions of different osmolarities, measured with a cryoscopic 
osmometer (Gonotec GmgH, Berlin, Germany). The isotonic bathing solution used for 
fluorimetric calcium measurements contained (in mM): 90 NaCl, 5 KCl, 1.3 MgCl2, 2.4 
CaCl2, 10 HEPES, 10 D-glucose, with pH adjusted to 7.4 with NaOH. 100 mM mannitol was 
added to maintain osmolarity constant at 300 mOsm/Kg. The hypoosmotic solutions (260 and 
210 mOsm/Kg) were prepared by reducing the final concentration of mannitol without 
changing the ionic composition. For the 170 mOsm/Kg solution [Na+] was reduced to 70 mM 
compared to standard buffer. For Ca2+- free solutions, calcium was omitted and replaced with 
5 mM EGTA. Experiments were performed at RT (22-26ºC). GsMTx-4 peptide was 
purchased from Peptides International (Louisville, Kentucky, USA).  
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Cell culture and transfection  
Human embryonic kidney (HEK) 293 cells (ECACC, Salisbury, UK) were grown in medium 
with 10% FBS and 1% of P/S and plated onto dishes coated with poly-L-lysine for 24-48 h 
before transfection. A stable HEK-293 line containing a tetracycline-inducible 5ptase IV was 
grown under conditions described by (Kisseleva et al., 2002). Both types of HEK-293 cells 
were transfected with the murine TRPC5 (1-2 μg) using Lipofectamine 2000; Invitrogen, 
Carlsbad, CA; 5 μl/μg DNA) on glass coverslips for 4-6 h. mTRPC5, cloned in the pCI-neo 
vector (kindly supply by D. Clapham, Harvard Medical School), was co-transfected with 
green fluorescent protein (GFP; Life Technologies). For specific experiments, rat type 1 
histamine receptor (H1, 0.2 μg/ml; kindly supply by T. Plant, Marburg University) was co-
transfected in HEK-293 cells with TRPC5 and GFP. Transfected cells were identified by GFP 
fluorescence. Induction of 5ptase IV cells was achieved by incubation with tetracycline (0.1 
μg/ml for 12-24 h). 
Trigeminal ganglion neurones from neonatal mice were cultured as described previously 
(Viana et al., 2001). In brief, trigeminal ganglia were isolated from anesthetised newborn 
Swiss OF1 mice (postnatal days 0 to 3), incubated with 1 mg/ml collagenase type IA (Sigma, 
St. Louis, MO) for 45 min at 37ºC in 5% CO2 and cultured medium:  45% DMEM, 45% F-12, 
and 10% fetal bovine serum (Invitrogen), supplemented with 4 mM L-glutamine (Invitrogen), 
200 μg/ml streptomycin, 125 μg/ml penicillin, 17 mM glucose, and nerve growth factor 
(NGF; mouse 7S, 100 ng/ml; Sigma, Sigma, St. Louis, MO). Cells were plated on poly-L-
lysine-coated glass coverslips and used 1 day after culture.  
Fluorometric calcium measurement 
Cells were incubated with 5 μM fura-2AM (Invitrogen) for 45 min at 37ºC in a 5% CO2 
incubator. Recordings were performed in a low-volume chamber with a complete solution 
exchange of ∼1 min. Fluorescence measurements were made with a Zeiss Axioskop FS 
upright microscope. Fura-2 was excited at 340 nm and 380 nm with a high speed 
monochromator (TILL Photonics, Germany) and the emitted fluorescence was long-pass 
filtered at 510 nm. Images were acquired using an Orca ER CCD camera (Hamamatsu 
Photonics, Japan). Acquisition and analysis were performed with Metafluor software 
(Molecular Devices Corporation, PA, USA). Cytosolic Ca2+ increases are presented as the 
ratio of the emission intensities of 340 and 380 nm (F340/F380:  fluorescence arbitrary units 
(F.A.U.)). Recordings were made alternately from coverslips with transfected and non-
transfected cells. GFP fluorescence was monitored with an excitation wavelength of 470 nm. 
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The change in cell volume during osmotic swelling was estimated from pairs of Fura-2 
fluorescence images recorded at the isosbestic wavelength for Ca 2+. The integral fluorescence 
intensity of an area that contained the whole cell at all times was divided by the integral 
fluorescence of a small spot within the cell. This fluorescence ratio is reciprocal to the 
cytosolic Fura-2 concentration and thus reflects the relative change in cell volume (Strotmann 
et al., 2000). 
Electrophysiology 
Whole-cell recordings were obtained using 3-5 MΩ borosilicate glass capillary patch pipettes. 
Current signals were recorded with a Multiclamp 700 amplifier and ramp voltage clamp 
commands were applied using pCLAMP software and a Digidata 1322A digitizer (Molecular 
Devices Corporation, Sunnyvale, CA, USA). Cells were held at a potential of –60 mV, and 
current-voltage (I–V) relations were obtained from voltage ramps from  –100 mV to +100 mV 
with a duration of 400 ms applied every 5s. Current was sampled at a frequency of 20 kHz 
and filtered at 5 kHz. Series resistance compensation of >50% was used. The internal solution 
contained (in mM): 135 CsCl, 2 MgCl2, 10 HEPES, 1 EGTA, 5 Na+2-ATP, pH 7.2 adjusted 
with CsOH and 300 mOsm/Kg. In some experiments, the pipette solution was modified by 
adding 10 μM diC8-PI(4,5)P2 (Echelon Bioscience, Salt Lake City, UT, USA). The bath 
solutions for whole-cell recordings were the same as the ones described for the fluorimetric 
calcium measurements at the bathing solutions and reagents section. In this case, we used a 
smaller recording chamber with a solution exchange time of ~35 sec. 
The pressure-clamp experiments were achieved through the application of controlled pressure 
steps via the patch-pipette, in whole cell configuration, using a high-speed pressure clamp 
system (HSPC-1, ALA Scientific Instruments, Westbury, NY; (Besch et al., 2002)). 
RT-PCR 
Total RNA was isolated from OF-1 adult mice trigeminal ganglia (TG), dorsal root ganglia 
(DRG), hippocampus and non transfected HEK-293 cells. Animals were terminally 
anesthetized with CO2 and the tissues of interest were rapidly removed. Total RNA was 
extracted from homogenized tissues from 4 animals combining an acid phenol extraction 
method (TRIzol reagent) and RNeasy mini-columns, (Qiagen, Crawley, UK). 2 μg of total 
RNA was reverse transcribed using random hexamers and Superscript TM II RT (Invitrogen) 
in a final volume of 20 μl for 1 hour at 42ºC, followed by 72ºC for 15 min to terminate the 
reaction. Control reactions for RT-PCR included the absence of the SuperScript II before PCR 
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and the absence of template which was replaced by water. Control reactions showed no 
amplification products. 2 μl of the cDNA was added to 18 μl of PCR reaction mixture and the 
specific primers mTRPC5sense 5’-CTATGAGACCAGAGCTATTGATG-3’ and 
mTRPC5antisense 5’-CTACCAGGGAGATGACGTTGTATG-3’ for mouse tissues RNA and 
hTRPC5sense 5’-TTATGAAACCAGAGCTATCGATG-3’ and hTRPC5antisense 5’-
CTACCAGGGAGATGACGTTGTATG-3’ for human HEK cells RNA.  
The cycling protocol used was 3 min at 95ºC, then 30 sec at 95ºC, 20 sec at 60ºC and 30 sec 
at 72ºC. Reaction samples were separated by standard agarose gel electrophoresis to confirm 
the specificity and the correct size of the PCR product.  
 
Immunocytochemistry 
For TRPC5 immunostaining detection, we used a monoclonal antibody (NeuroMab, UC 
Davis/NIH, Davis CA, USA). The specificity of the anti-TRPC5 staining was verified in non- 
transfected HEK-293 cells and in TRPC5-GFP transfected cells (Supplemental Fig. S1). 
Coverslips with cultured trigeminal neurones and HEK-293 cells were fixed for 10 minutes at 
room temperature (RT) with 4% paraformaldehyde in PBS. The fixed cells were 
permeabilised and blocked with 0.1% Triton X-100, 2% goat serum, 1% BSA and 0.05% 
Tween 20 for 25 minutes and thereafter incubated with the primary antibody against TRPC5 
at 1:100 concentration in PBS containing 2% goat serum and 1% BSA for 2 h at RT, then 
rinsed three times for 2 min at RT and incubated with goat anti-mouse IgG secondary 
antibody (Sigma, St. Louis, MO) (Alexa fluor 594) at 1:800 concentration. Following 
thorough wash with PBS, the coverslips were stained with Hoechst (1:1000) and mounted 
onto slides with Fluoromount-G (Southern Biotech, USA). Cell staining was examined with a 
laser scanning spectral microscope (Leica TCS SP2 AOBS, Leica Microsystems, Heidelberg, 
Germany) using a 63x objective with sequential acquisition settings at 1024x1024 pixel 
resolution. Omission of the primary antibody gave no specific staining and the same laser 
intensity parameters used for the detection of secondary antibody staining were used to 
acquire images after incubation with anti-TRPC5. Regions of interest (ROI) were delineated 
over individual neurones. Neuronal profiles from 12 fields of 3 independent experiments were 
identified by their characteristic cellular morphology. The fluorescence intensity was 
represented by 8-bit colour scale (range from 0 to 256 coding intensities). The average value 
of the non-specific fluorescence intensity was determined in neurones incubated only with the 
secondary antibody. Those neurones whose mean fluorescence intensity exceeded the average 
of non-specific fluorescence intensity plus twice its standard deviation were counted as 
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positive. The analysis of labelled neurones was made using the Leica confocal software and 
the NIH ImageJ software (Rasband, 2007). Final brightness and contrast were adjusted with 
Photoshop CS2 (Adobe Systems, USA). 
 
Data analysis 
Data were analyzed with WinASCD software (G. Droogmans, KULeuven, Belgium) and 
Origin 7.5 (OriginLab Corporation, Northampton, MA, USA). When comparing mean 
amplitude of current increments, we assigned a zero value to non-responding cells for treated 
and non-treated cells. All data are expressed as means (± SEM). Statistical tests included one-
way analysis of variance (ANOVA), the Z-test for comparing proportions and Student’s t-test, 
as indicated. Differences were regarded as statistically significant (*) for P < 0.05, (**) for P 
< 0.01 and (***) for P < 0.001. 
 
 
RESULTS 
TRPC5 is activated by hypoosmotic-induced cell swelling. We used fura-2 calcium 
imaging to evaluate the response of HEK-293 cells co-transfected with murine TRPC5 and 
green fluorescent protein (GFP) (Fig. 1A) to extracellular perfusion with a hypoosmotic 
solution (210 mOsm) (Fig. 1C). Transient exposure for 4 minutes to a 210 mOsm solution 
induced a reversible increase in [Ca2+]i levels in ∼25% of GFP positive cells (Fig. 1C,1D,1F). 
The image 1C corresponds to the time course of calcium increase indicated by the arrow in 
figure 1D. In the presence of 2.4 mM extracellular Ca2+, hypoosmotically-evoked responses 
were transient and variable from cell to cell, with a delay ranging from 2-4 min after external 
medium change and with a delay of 72 ± 14 sec (n= 20 cells) measured from the onset of the 
volume change produced by the hypoosmotic challenge. Supplemental Fig S2. shows the time  
course of the relative cell volume increase and the [Ca2+]i response recorded simultaneously 
in the same cells, indicating the individual differences in the latency of responses after 
hypoosmotic change. Responses in GFP(–) cells to hypoosmotic stimuli were minimal (Fig. 
1E, F; n= 1555) and undistinguishable from mock transfected cells (i.e. cells co-transfected 
with the empty vector and GFP; Fig 1F, n=156). The rise in [Ca2+]i in responding cells 
averaged 0.25 ± 0.04 (n = 527) fluorescence arbitrary units (F.A.U.) and was entirely 
attributable to calcium flow across the plasma membrane because it was abolished when we 
replaced Ca2+ in the superfusion medium with 5 mM EGTA (Fig. 1F; n = 195). We 
investigated further the possibility that Ca2+ released from intracellular stores contributes to 
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the hypoosmotic-induced [Ca2+]i increases by depletion of the intracellular stores. The bar 
histogram in Fig. 1G summarised the effect of incubating the cells with 2 μM thapsigargin, an 
inhibitor of the endoplasmic reticulum Ca2+-ATPase (Thastrup et al., 1990), for 1 h. The 
depletion of intracellular calcium stores affected neither the percentage of responses of 
TRPC5 (+) (Fig. 1G) nor the amplitude of the responses (0.35 ± 0.03 F.A.U; n = 307) to 
hypoosmotic stimulus in the presence of extracellular calcium compared with the responses of 
cells incubated with 2 μM DMSO, the vehicle of thapsigargin (0.35 ±0.04 F.A.U; n= 169). In 
contrast, carbachol (Cch) induced Ca2+ release was almost abolished in thapsigargin-treated 
cells (Fig. 1G).
 
These results demonstrate that the hypoosmotic-evoked [Ca2+]i increase in 
TRPC5 (+) cells is due to influx of extracellular calcium through activated TRPC5 channels.  
Next, we studied the sensitivity of the channel to stimuli of different intensities by testing the 
effect of extracellular solutions with decreasing osmolarities (260, 210 and 170 mOsm/Kg) on 
[Ca2+]i responses in TRPC5-transfected cells. A representative example is shown in the traces 
of Fig. 2A. The main effect of graded decreases in osmolarity was an increase in the 
percentage of cells responding to each stimulus (Fig. 2B). In contrast, the amplitude of the 
responses varied from cell to cell but was similar for the three stimuli (Fig. 2C).  
To rule out the possibility that the more frequent response to 170 mOsm solution is due to 
sensitisation of the cells from two previous applications of hypoosmotic stimulus, we 
analysed, in a different set of experiments, the responses of cells to applications of a single 
hypoosomotic stimulus of variable strength. In this case, the percentage of cells responding to 
260 and 210 mOsm/kg are half (20% and 23% respectively) of the percentage of cells that 
respond at 170 mOsm/kg (56%) (Fig. 2E). This result is similar to what was found when all 3 
stimuli were applied consecutively which suggest that there is no significant sensitisation or 
desensitisation after consecutive stimulation (Fig. 2B). Again, when a single hypoosmotic 
stimulus is applied, no clear trend was observed between the strength of the osmotic stimulus 
and the increase in fluorescence in the responsive cells (Fig 2F).  
 
Hypooosmotic solution activates TRPC5 channels 
To demonstrate that the osmotic stimuli activate membrane TRPC5 channels, we measured 
whole-cell ionic currents in response to application of hypoosmotic solutions in cells co-
transfected with TRPC5 and GFP.  As shown in Fig. 3A for a typical experiment, application 
of a hypoosmotic stimulus induced a large, slowly reversible whole-cell current. Fig. 3B 
shows, for the same cell, the I–V relationship of the ramp current evoked in control solution 
and at the peak of the response to hypoosmotic stimulation. The current displays the 
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characteristic doubly rectifying shape of TRPC5-mediated currents (Schaefer et al., 
2000;Strubing et al., 2001). The reversal potential of the osmotically-activated current 
averaged –8.3 ± 0.6 mV (n=36). Currents were recorded in TRPC5(+) cells with a mean 
amplitude of –0.276 ± 0.075 nA at –80 mV and 0.564 ± 0.137 nA at +80 mV (Fig 3C, n= 67). 
The delay between the application of the hypoosmotic stimulus and the onset of the response 
was 119 ± 16 s, comparable to delays measured during calcium imaging experiments. In 
contrast, hypoosmotical stimulation did not activate currents with the characteristic TRPC5 
signature in cells transfected with the empty vector pCI-Neo (data not shown; n=5) indicating 
that HEK293 cells lack TRPC5-like endogenous currents. This is in good agreement with the 
results of (Obukhov & Nowycky, 2008).  
Removal of calcium from the extracellular solution prevented the hypoosmotic-activated 
TRPC5 current, which recovered after adding calcium to the extracellular medium (Fig. 3D). 
Fig. 3E shows the I–V relation of the whole-cell current at the peak of the response in control 
solution, in the absence of and after adding calcium (colour points in Fig. 3D). In nominally 
Ca2+-free external solution with 10 mM EGTA in the pipette, hypoosmotic stimuli did not 
activate TRPC5-like currents (n=14; Fig. 3F). Even with 1mM EGTA in the pipette, 
responses were abrogated (only 1 out of 23 TRPC5(+) recorded cells responded to 
hypoosmotic stimulus; Fig. 3F). These results show that intracellular Ca2+ chelation hampers 
osmotic activation of TRPC5, a result in agreement with activation of TRPC5 by stimulation 
of G-protein-coupled receptors (Okada et al., 1998; Plant & Schaefer, 2003). 
 
Specific blockade of stretch-activated channels inhibits hypoosmotic-induced TRPC5 
activation.  
GsMTx-4 is a tarantula peptide having potent blocking actions on stretch-activated channels 
(Suchyna et al., 2000; Hamill, 2006). Thus, we measured TRPC5-dependent currents during 
hypoosmotic stimulation in GsMTx-4-treated cells. As shown in Fig. 4A, 5 μM GsMTx-4 
strongly reduced TRPC5 currents during hypoosmotic stimulation. The inhibition was 
reversible upon wash and a typical TRPC5-dependent current was obtained during application 
of a second hypoosmotic stimulus. The I–V relationship at maximal activation for 
hypoosmotic stimulation in the presence and after wash of GsMTx-4 is represented in Fig. 
4C. All the recorded TRPC5 (+) cells responded to hypoosmotic stimulation (n=10; Fig. 4E) 
with an average increase of 0.324 ± 0.09 nA at -80 mV and 0.431 ± 0.128 nA at +80 mV (Fig. 
4F), however only 1 of the 8 cells treated with GsMTx-4 responded to the hypoosmotic 
stimulation at -80 mV and 3 of 8 cells at +80 mV (in average, 0.006 nA at -80 mV and 0.05 ± 
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0.03 nA at +80 mV; Fig. 4E-F). The block of hypoosmotically-induced current activation was 
more effective on the inward component of the current (Fig. 4C), consistent with a block 
occurring at the extracellular side (Suchyna et al., 2004). These results argue that the toxin 
blocks the activation of TRPC5 by osmotic-induced membrane stretch. 
TRPC5 channels are known to activate following stimulation of G-protein coupled-receptors 
of the Gq/11 family which couple to phospholipase Cβ (PLCβ) (Plant & Schaefer, 2005; Beech, 
2007). Co-transfection of TRPC5 and type 1 histamine (H1)1 receptors has been used by some 
authors chracterizing activation of TRPC5 (Schaefer et al., 2000; Jung et al., 2003; Obukhov 
& Nowycky, 2004; Obukhov & Nowycky, 2008). Indeed, histamine application evoked large, 
consistent inward and outward currents in TRPC5 transfected cells. Therefore, we also 
studied current activation to hypoosmotic solution in GsMTx-4-treated cells co-transfected 
with TRPC5 and H1 receptors, a canonical Gq/11-coupled receptor. Interestingly, H1-
mediated activation of TRPC5 was also affected by the toxin. The activation of the current 
evoked by 100 μM histamine was potently and reversibly blocked in the presence of GsMTx-
4 (Fig. 4B). The residual current had a much slower rise time and the peptide reduced the 
current amplitude significantly; only 3 of the 10 recorded cells responded to 100 μM 
histamine (Fig. 4E). Figure 4D shows the typical double rectified I–V relationship of the 
TRPC5 current activated after removal of the toxin. The amplitude of the current activated by 
100 μM histamine was almost fully blocked by the toxin at negative potentials (it diminished 
from 1.34 ± .235 nA to 0.07 ± 0.05 nA at -80 mV) and was also strongly reduced at positive 
potentials (from 1.7 ± 0.3 nA to 0.15 ± 0.11 nA at +80 mV (n=10); Fig. 4F). All together 
these results indicated that TRPC5 channels are blocked by a toxin having effects on stretch-
activated channels. 
 
Phospholipase activity is not required for osmotic activation of TRPC5 
Next, we tried to dissect the signalling pathway involved in the hypoosmotic activation of 
TRPC5 channels. We asked whether phospholipase C (PLC), the canonical mechanism for 
receptor-mediated activation of TRPC5 (Schaefer et al., 2000; Putney, Jr., 2004) is involved. 
To this end, we tested the PLC inhibitor U-73122 in cells transfected with TRPC5. As shown 
in the representative trace of Fig.5A, treating cells with 5 μM U-73122 did not prevent 
activation of TRPC5 currents by hypoosmotic solutions. In contrast, U-73122 fully abrogated 
the response to application of 10 μM Cch that activates endogenous muscarinic Gq-coupled 
receptors in this clone of HEK-293 cells. Figures 5B and 5C summarise these results. After 
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incubation with U-73122, all recorded cells (n = 6) responded to hypoosmotic stimulation 
(Fig. 5B) with an average current increase identical to that of non treated cells (0.221 ± 0.09 
nA at -80 mV and 0.531 ± 0.24 nA at +80 mV in treated cells versus 0.212 ± 0.17 nA at -80 
mV and 0.526 ± 0.366 nA at +80 mV in control cells; n = 8, Fig. 5C). On the other hand, only 
1 of 6 cell (Fig.5B) responded to 10 μM Cch after U-73122 incubation with a average current 
increase of 0.016 ± 0.014 nA at -80 mV and 0.036 ± 0.005 nA at +80 mV (Fig. 5C) whereas 
all cells responded to Cch in control conditions (0.385 ± 0.197 nA at -80 mV and 0.603 ± 
0.211 nA at +80 mV; n=12, Fig. 5C). Incubation with U-73343, an inactive analogue with 
little or no effect on PLC activity, did not affect the activation of TRPC5 channels, neither by 
hypoosmotic solution (n=8) nor by Cch (n=8). From these results it is clear that the activation 
of TRPC5 by hypoosmotic solution is not attributable to osmotic activation of PLC (Osol et 
al., 1993). 
Cell swelling can also activate phospholipase A2 (PLA2) (Pedersen et al., 2000) and the 
osmotic activation of the TRPV4 channel is thought to be secondary to PLA2-dependent 
synthesis of AA (arachidonic acid), which is then metabolized to 5’-6’ EET (Vriens et al., 
2004). We used N-(p-amyl-cinnamoyl)anthranilic acid (ACA), a potent inhibitor of PLA2, to 
test the involvement of this enzyme in the osmotic activation of TRPC5. As shown in Fig. 5D, 
pre-incubation with 20 μM ACA did not prevent [Ca2+]i increases (0.32 ± 0.025 F.A.U. n = 74 
in 4 independent experiments) evoked by hypoosmotic stimulation. Figure 5E shows the 
typical TRPC5-mediated whole-cell current, during 210 mOsm stimulation, in a cell pre-
incubated with 20 μM ACA: 3 out of 4 cells responded to ACA with mean current amplitude 
of 0.369 ± 0.216 nA at -80 mV and 0.533 ± 0.250 nA at +80 mV. This amplitude is similar to 
that obtained in untreated TRPC5(+) cells. Figure 5F shows, in the same cell, the I–V 
relationship of the ramp current in control solution and at the peak of the response to 
hypoosmotic stimulation in the presence of ACA. As a matter of fact, an increase in the 
current was consistently observed after application of ACA (Fig. 5F) (Kraft et al., 2006).   
 
Activation of TRPC5 by hypoosmotic stimuli depends of intracellular PIP2 levels. 
Stimulation of phospholipase C-activating receptors cause hydrolysis of the membrane trace 
lipid phosphatidylinositol 4,5-bisphosphate (PIP2). Recent studies have highlighted the 
important role of PIP2 in the gating of many ion channels (Suh & Hille, 2005; Gamper & 
Shapiro, 2007) particularly TRP channels (reviewed by Qin, 2007). Therefore, we tested 
whether PIP2 could be involved in the activation of TRPC5 channels by osmotic stretch. To 
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this end, we transfected TRPC5 into a HEK293 cell line stably expressing, under tetracycline 
control, a phosphoinositide-specific inositol polyphosphate 5-phosphatase IV (5ptase IV). In 
this cellular system, induction of 5ptase IV caused an 8- to 15-fold depletion of PIP2 levels 
(Kisseleva et al., 2002). As shown in Fig. 6A, B in non-induced cells, labelled tet(-), 
hypoosmotic solutions evoked robust TRPC5 currents. Figures 6F-G summarise the 
percentage of cells that responded to different experimental conditions and the averaged 
amplitude of the responses, respectively. 14 out of 17 cells responded to hypoosmotic solution 
(0.381 ± 0.121 nA at -80 mV and 0.550 ± 0.152 nA at +80 mV) in control conditions. In 
contrast, in PIP2-depleted cells, labelled tet(+), the responses to hypoosmotic stimuli was 
significantly reduced and was observed in only 5 of 26 cells (Fig. 6F). Furthermore, the 
amplitude of the current activated by hypoosmotic stimuli was strongly and significantly 
reduced (measuring on average 0.022 ± 0.019 nA at -80 mV and 0.0085 ± 0.061 nA at +80 
mV). As an additional control for PIP2 depletion, we analysed the activation of the TRPC5 
channels following stimulation of G-protein coupled-receptors via activation of the 
endogenous P2Y receptors expressed in this particular cell line (Chen et al., 2006). In 16 of 
the 17 untreated TRPC5(+) cells tested, application of 500 μM ATP activated a robust 
TRPC5-like current (on average 0.680 ± 0.155 nA at -80 mV and 0.757 ± 180 nA at +80 mV; 
Fig 6A, B, F, G). In contrast, in PIP2-depleted cells, the responses to ATP were strongly 
reduced and only 8 of 26 cells were activated by ATP (in average 0.021 ± 0.009 nA at -80 mV 
and 0.071 ± 0.035 nA at +80 mV; Fig. 6C, D). If PIP2 underlies the hypoosmotic- and ATP 
mediated current activation, the application of exogenous PIP2 to PIP2-depleted cells should 
lead to current recovery. We added diC8-PIP2, a water-soluble form of PIP2, to the 
intracellular patch pipette solution and were able to recover the hypoosmotic activated current 
in 6 of 10 tet(+) cells, a percentage of responses similar to the one found in tet(-) cells. The 
current amplitude also increased modestly, without reaching the significance levels (in 
average, 0.067 ± 0.022 nA at -80 mV and 0.202 ± 0.095 nA at +80 mV; Fig. 6G). In contrast, 
the responses to ATP were only recovered in 3 of the 10 cells tested (data not shown).  
We also tested the role of PIP2 in the increases of [Ca2+]i evoked by hypoosmotic stimulation 
of cells transfected with TRPC5. Hypoosmotic stimulation of control (i.e. non-induced) cells, 
elevated [Ca2+]i in 18% of the TRPC5(+) cells (Fig. 6H, J) with an increase of 0.25 ± 0.19 
F.A.U. (60 of 328 cells in three independent experiments). The cells also responded to 500 
μM ATP (0.96 ± 0.17 F.A.U.; 284 of 289 cells from 8 independent experiments; Fig. 6H, J). 
After induction of the 5ptase IV, the response to hypoosmotic solution was fully abrogated 
(n=114), while the response to ATP was strongly reduced (19.3%, n=114; Fig. 6I, J). The 
  
13
mean calcium increase of the ATP-responding cells also decreased to 0.5 ± 0.1 F.A.U. 
Overall, these data indicate that basal membrane PIP2 levels are required for hypoosmotic and 
agonist-mediated activation of TRPC5 channels. 
 
Membrane stretch induced by pressure activates the TRPC5 channel 
Gating of mechano-sensitive cation channels has been studied in the whole-cell configuration 
by applying positive pressure through the patch pipette (Hamill & McBride, Jr., 1997). Such 
manipulations increase the cell volume and exert membrane stretch in much the same way as 
hypotonic solutions. The significant difference with hypotonic swelling, however, is that 
pressure-induced inflation occurs without altering the cytosolic concentrations of ions, as 
occurs during hypotonic swelling. Using a fast pressure-clamp technique (Bessac & Fleig, 
2007), we studied the pressure-induced activation of the TRPC5 channel. We kept TRPC5 
transfected cells in the standard external and internal (patch pipette) solutions. Membrane 
stretch was induced by positive pressure applied to the patch pipette. Application of repeated 
positive pressure pulses of increasing amplitude from 10 to 140 mmHg activated a doubly 
rectifying current in TRPC5(+) cells (Fig. 7A-B). Figure 7A shows the whole-cell current 
induced by positive pressure at -80 and +80 mV. The channel was activated when the pressure 
reached an average threshold of 21.3 ± 2.7 mm of Hg in 16 of the 19 recorded cells, with an 
average increment in current of 0.497 ± 0.116 nA at -80 mV and 1.58 ± 0.22 nA at + 80 mV 
(n= 19 cells; Fig. 7C). Following a variable delay after pressure application, the onset of 
current activation was 22 ± 5.6 s which is considerable shorter than delays measured during 
hypoosmotic-current activation. Upon removal of the intracellular positive pressure, the 
current slowly declined to basal levels. The reversal potential of the stretch-activated current 
was close to zero (-0.3 ± 0.6 mV; n = 16). Figure 7B shows, in the same cell, the I–V 
relationship of the ramp current in control solution and at the peak of the response to pressure 
stimulation (30 mm Hg in this case). 
In some experiments we were able to apply consecutively both stimuli, i.e. hypoosmotic 
solution followed by positive pressure, to the same cell. All TRPC5(+) cells tested (n=5) 
responded to both stimuli without statistically significant differences in current amplitude 
(Fig.7D-E). As occurred with hypoosmotic stimulation, positive pressure application did not 
activate currents with the characteristic TRPC5 signature in cells transfected with the empty 
vector pCI-neo (Fig. 7F; n=11). 
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TRPC5 channel is expressed in mouse primary sensory neurones 
We used specific primers for mouse TRPC5 to determine the expression of the channel in TG 
and DRG ganglia and in hippocampus. Our RT-PCR analysis showed that TRPC5 was 
expressed in the tested tissues (Fig. 8A). Next, we examined TRPC5 protein expression in 
mouse ganglia using immunocytochemical staining. TRPC5 was detected in 62% of all TG 
neurones (n= 295 from 12 different fields, from 3 experiments). Figure 8 show representative 
images of TG cultured cells under visible illumination (B) and the fluorescence image after 
labelling with an antibody against TRPC5 (C). Figure (D-E) shows the lack of labelling when 
omitting the primary antibody. The histogram of figure 8F shows the size distribution plots of 
neurones expressing and not expressing TRPC5, with average sizes of 110 ± 4 μm2 (n=183) 
and 111 ± 6 μm2  (n= 112) respectively. 
 
DISCUSSION 
Mechano-detection is essential for many physiological processes like touch, hearing and 
blood pressure control. Nonetheless, the molecular identity of ion channels sensing 
mechanical forces in tissues remains uncertain (Christensen & Corey, 2007; Venkatachalam 
& Montell, 2007; Lumpkin & Caterina, 2007). Moreover, how mechanical deformation of the 
cell membrane translates into channel activity is not firmly established. Genetic studies in C. 
elegans and fruit flies support the involvement of TRP channels in mechanotransduction 
(Colbert et al., 1997; Christensen & Corey, 2007; Kahn-Kirby & Bargmann, 2006). In 
mammals there is also fragmentary evidence supporting a role for TRP channels in mechano- 
and osmodetection (reviewed by Pedersen & Nilius, 2007). Thus, TRPV4 channels contribute 
to activation of high-threshold cutaneous mechanoreceptors (Suzuki et al., 2003; Alessandri-
Haber et al., 2004), hypothalamic osmoregulation (Liedtke & Friedman, 2003; Liedtke, 2007; 
Bourque, 2008), and bladder voiding responses (Gevaert et al., 2007). Also, several TRPs, 
including TRPC1, TRPC3, TRPC6, TPV2 and TRPM4 have been implicated in the regulation 
of myogenic vascular tone (Beech, 2005; Christensen & Corey, 2007).  
Our study shows that TRPC5, a widely expressed ion channel in mammalian tissues, is 
activated by swelling and pressure-induced membrane stretch. The TRPC5 current activated 
by hypoosmotic stimulation is dependent on extracellular Ca2+. Furthermore, current 
activation is also prevented by intracellular Ca2+ buffering, suggesting that Ca2+ elevation and 
basal Ca2+ levels are needed to sustain activation of the channel. These findings agree with the 
receptor-mediated activation of TRPC5 which is also strongly dependent on [Ca2+]i elevation 
(Schaefer et al., 2000). A channel that is calcium permeable and calcium-activated represents 
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a typical example of a positive feedback mechanism. Thus, calcium influx induced by 
membrane stretch may explain the variability in the responses and the lack of a clear relation 
between stimulus strength and current amplitude. Moreover, membrane stretch induced by 
application of positive pressure through the patch pipette, also activated TRPC5 channels, 
suggesting that their gating is closely related to membrane tension rather than being 
secondary to changes in intracellular signalling factors.  
The blocking effect of GsMTx-4, a specific modifier of nonselective mechanosensitive 
channels (Suchyna et al., 2000; Park et al., 2008) further supports the tenet that TRPC5 could 
acts as a membrane stretch transducer. Our data concur with the model proposed by Spassova 
et al, (2006) to explain the inhibition of TRPC6 channels by GsMTx-4. In control conditions, 
hypoosmotic stimulation leads to cell swelling and membrane stretch. These forces are 
transmitted through the lipid bilayer to gate the channel into the open state. Insertion of 
GsMTx-4 in the outer leaflet of the membrane relieves the lipid stress leading to channel 
closure. GsMTx-4 also inhibits the activation of TRPC5 by receptor stimulation which 
favours the idea that the toxin is blocking the channel and it is not acting on a possible 
mechanosensitive element upstream of TRPC5 activation. According to the model, activation 
of PLC-coupled receptors produces a breakdown of the charged PIP2 molecules to form the 
uncharged DAG. This change in lipid geometry produces stress and/or exposure of channel 
residues and opening. As occurs with stretch-activation, GsMTx-4 inserts in the bilayer and 
relieves lipid stress. Although neither DAG nor arachidonic acid or other fatty acids activate 
TRPC5 (Schaefer et al., 2000), PLC metabolizes other membrane phospholipids that could 
modify the structure of the membrane. Thus, the toxin could inhibit the activation by a similar 
mechanism as for the direct stretch activation. Moreover, we showed that PLA2 that is 
activated by cell swelling and mediates the osmotic activation of TRPV4 (Vriens et al., 2004), 
is not involved in the osmotic activation of TRPC5. Finally, our results also show that the 
osmotic activation of TRPC5 was still observed in the presence of the PLC inhibitor U-73122 
indicating that TRPC5 channels are activated by hypoosmotic membrane stretch through a 
PLC-independent mechanism.  
PIP2 is emerging as a critical modulator of many TRP channels (Qin, 2007; Lukacs et al., 
2007; Brauchi et al., 2007). Ours results clearly show that PIP2 is necessary for both, 
hypoosmotic activation and PLC-coupled receptor activation of the TRPC5 channel. 
Furthermore, reintroducing a water-soluble PIP2 analog in the cell recovered the response to 
mechanical and receptor-mediated activation, suggesting that the role of PIP2 is upstream of 
both signalling pathways, perhaps intimately linked to the gating of the channel itself. By 
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analogy with previous work, it could be speculated that electrostatic interactions between PIP2 
and positively charged intracellular residues of the channel lead to stabilization of the open 
state (Suh & Hille, 2005; Gamper & Shapiro, 2007; Voets & Nilius, 2007). More complex 
scenarios involving indirect interactions between PIP2 and TRPC5 are also possible. The 
recruitment of new TRPC5 channels to the plasma membrane by epidermal growth factor is 
also dependent on PIP2 (Bezzerides et al., 2004). However, the fact that PIP2 is required for 
the activation of TRPC5 by the hypoosmotic stimulus seems at odds with a receptor-mediated 
activation of TRPC5 that should lead to PLC activation and decreased membrane PIP2 levels. 
The apparent bell-shaped relationship between membrane PIP2 levels and TRPC5 activity 
resembles the dependence of IP3 receptors on Ca2+ levels (Bezprozvanny et al., 1991). 
Another possibility to consider is the affinity of TRPC5 for PIP2. For channels with apparent 
high affinity for PIP2, a moderate depletion of PIP2 (as could be the case for the depletion of 
PIP2 after PLC-coupled receptor activation) would not inhibit activity (Rohacs, 2007). In 
contrast, a more severe depletion would hamper the gating of the channel. Other hypothetical 
explanations for this conundrum follow. Activation of TRPC5 following PLC stimulation 
may depend on other, yet unidentified, signalling molecule. Distinct pools of PIP2 molecules 
with differential accessibility to PLC may exist as well (Lukacs et al., 2007). This dual role of 
PIP2 on gating has been observed in TRPC6 channels in mesenteric artery myocytes. In this 
case, PIP2 is a precursor for DAG production for channel activation and a direct inhibitor of 
the ion channel (Albert et al., 2008). Recent work (Trebak et al., 2008) also supports the 
complex regulation of TRPC5 by PIP2, proposing that polyphosphoinositides may have at 
least two distinct functions in regulating TRPC5 channel activity. 
Mechanically sensitive channels that are gated directly by the mechanical stimulus are 
expected to respond with delays in the order of ms (Christensen & Corey, 2007). Our 
observed delays for TRPC5, in the range of seconds, suggest that the activation mechanism is 
indirect. It could involve activation of second messenger cascades or  
phosphorylation/dephosphorylation mechanism (Pedersen & Nilius, 2007; Lewin, 2008). 
However, it is possible that TRPC5 is part of a multi-protein complex in vivo and the 
observed delays reflect a poor coupling efficiency between the channel and the force sensing 
mechanism. Investigations on genetically modified mice may provide clues about these 
various possibilities. 
TRPC5 is highly expressed in the frontal cortex, hypothalamus, hippocampus and visceral 
sensory neurones (Philipp et al., 1998; Riccio et al., 2002; Greka et al., 2003; Glazebrook et 
al., 2005; Fowler et al., 2007). Still, little is known about its possible role in sensory 
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transduction. Using RT-PCR and inmunocytochemistry we show the presence of TRPC5 in 
trigeminal sensory neurones, thus extending previous data about the expression of TRPC5 in 
neurones of the hippocampus and DRG (Philipp et al., 1998; Greka et al., 2003; Wu et al., 
2008). Neurones expressing TRPC5 in the trigeminal ganglion were mainly of small diameter. 
Most of the small neurones in sensory ganglia are nociceptive, and respond to noxious 
mechanical forces, either exclusively (high threshold mechanosensitive neurones) or 
combined with other transduction capacities (polymodal nociceptor neurones) (Felipe et al., 
1999; Chen et al., 1995). Therefore, the possibility that TRPC5 expression is associated with 
the mechanosensitive properties of nociceptive neurones must be considered. At least three 
distinct types of mechanosensitive channels have been identified, contributing to the 
transduction of mechanical forces by primary sensory neurones, each with different pressure 
thresholds and biophysical properties (Cho et al., 2002; Hu & Lewin, 2006).  Their molecular 
identity remains unknown. Another TRP channel expressed by cutaneous sensory neurones, 
TRPV4, is also activated by osmotic swelling and participates in high threshold mechanical 
responses (Suzuki et al., 2003; Alessandri-Haber et al., 2004). Large local changes in tonicity 
occur in the skin during pain-enhancing inflammatory conditions in vivo (Cao et al., 2000; 
Liu et al., 2007). Moreover, Liu et al. (2007), have shown recently that changes in osmolarity 
sensitise TRPV1-mediated capsaicin responses in trigeminal ganglion. We showed a marked 
block of TRPC5 by GsMTx-4. Interestingly, this toxin, reduced mechanically evoked pain-
like behaviour in rats (Park et al., 2008).  
A possible function of TRPC5 as a mechano-osmotic transducer also correlates well with its 
expression pattern in tissues that are subjected to strong hydrostatic forces, like vascular and 
gastric smooth muscle and renal podocites. Recent studies in TRPC1(-/-) and TRPC6(-/-) 
mice suggests that, contrary to previous claims, TRPC1 and TRPC6 are not an obligatory 
component of stretch-activated ion channel complexes in vascular smooth muscle cells 
(Dietrich et al., 2007; Gottlieb et al., 2008; Sharif-Naeini et al., 2008). It is known that TRPC 
channels can form functional heteromeric complexes (Hofmann et al., 2002; Strubing et al., 
2001). In light of our findings, we propose that heteromeric assemblies of TRPC5 with other 
TRPC subunits may have mechanosensitive properties. In this case, elimination of a single 
subunit may be compensated by the formation of homeomeric complexes retaining 
mechanosensitivity. Further studies in TRPC5 k.o mice and double mutants should clarify 
their physiological role in mechano-transduction and osmotic regulation. In the meantime, 
caution is needed before ascribing a definitive role to TRPC channels in physiological 
transduction of mechanical forces. 
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FIGURE LEGENDS 
 
Fig. 1. Hypoosmotic-induced membrane stretch activates TRPC5 channel. Pseudocolor 
images of GFP-TRPC5-transfected cells showing GFP-fluorescence (A) and ratiometric 
[Ca2+]i responses to control (B) and 210 mOsm (C) solutions. Changes in [Ca2+]i are reflected 
by the ratio of fura-2 emission at 340 versus 380 nm excitation wavelength (see color bar). 
Scale bar, 50 μm. (D) Time course of the calcium changes during hypoosmotic solution 
exposure in cells transfected with TRPC5 and in non-transfected cells (E) in the same field. 
The image 1C corresponds to the time course of calcium increase indicated by the arrow in 
figure 1D. For each experiment, 50-75 cells in the field were selected at random and identified 
as GFP(+) and GFP(–). (F) Percentage of cell responding to 210 mOsm solution exposure in 
cells expressing TRPC5 under the indicated experimental condition (***, P < 0.001,Z-test; 
each condition in >3 independent experiments). The (*) denotes statistical significance 
between cells transfected with TRPC5 in the absence of calcium, untransfected cells and cells 
transfected with the empty vector versus cell transfected with TRPC5 in the presence of 
extracellular calcium. (G) Bar histograms summarizing the responses of TRPC5 positive cells 
after incubation with 2μM thapsigargin compared with cell incubated with 2μM DMSO in a 
number of cells > 150 in six independent experiments (**P < 0.001; Z-test). 
 
Fig.  2. Osmolarity-dependence of responsive cells in fura-2-loaded HEK293 cells 
expressing TRPC5.  (A) [Ca2+]i changes in response to reduction in extracellular osmolarity 
from 300 mOsm/Kg to the indicated values (for these set of experiments the fura-2 
fluorescence was measured at its isosbestic point). (B-F) Bar histograms summarising the 
percentage of responsive cells and the mean evoked [Ca2+]i elevation after consecutive steps 
in hypoosmolarity at the same cell (B, C; n= 576) and after application of one of the indicated 
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solution (E, F; n=271 for 260 mOsm, n=187 for 210 mOsm and n=45 for 170 mOsm). **P < 
0.01; ***P < 0.001; Z-test and One way ANOVA). In B and E the asterisks denote statistical 
significance compared to maximal response obtained (170 mOSm/kg). In C and F the 
comparison were made between the experimental conditions. 
 
Fig.  3. Osmotically-induced whole cell currents in cells expressing TRPC5. (A) 
Representative experiment showing the peak whole-cell current, measured at ± 80 mV, 
obtained from ± 100 mV voltage ramps in a cell expressing TRPC5 during application of 210 
mOsm solution (B) I–V relationships obtained in control solution and at maximal current 
from the same cell as in (A). (C) Summary of the mean increase in current obtained in 
responsive cells to hypoosmotic stimulation (n= 67 cells) measured at -80 and +80 mV. (D) 
Whole-cell current (± 100 mV voltage ramps) in cell expressing TRPC5 during exposure to 
210 mOsm solution in the presence and absence of extracellular calcium. (E) I–V relationship 
from the same cell as in (D) in the different experimental conditions. (F) Histogram 
summarizing the amplitude of the whole-cell current in TRPC5-expressing cells responding to 
hypoosmotical solution in the presence and absence of calcium, and different EGTA pipette 
concentrations from the type of experiment shown in (D). * P < 0.01 and *** P < 0.001 
compared to responses in 2.4 mM external calcium (Student’s t-test). 
 
Fig. 4. The tarantula peptide GsMTx-4 inhibits the activation of TRPC5 by 
hypoosmotical stimulation. (A) Whole-cell currents evoked by hypoosmotic solutions in a 
TRPC5 transfected cell pre-incubated for 20 minutes with 5 μM GsMTx-4 before recording. 
(B) Responses to 100 μM histamine in a cell transfected with TRPC5 and H1 receptor in the 
presence of GsMTx-4 and after wash out of the toxin.; same pre-incubations as in A. (C-D) I–
V relationships corresponding with the time points marked in colors in A and B respectively. 
(E) Bar histogram summarizing the effect of GsMTx-4 on the percentage of responsive cells 
the block of the cell responses to hypoosmotic stimulation and histamine in control solution 
and in the presence of the toxin (* P < 0.05, compared with non-treated cells; Z-test).  (F) The 
increases in current of the responsive cells measured at -80 and + 80 mV are summarised at 
the histogram. ** P < 0.01 compared with control cells for each type of stimulation (Student’s 
t-test). 
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Fig. 5.  Gating of TRPC5 by hypoosmotical stimulation is independent of phospholipase  
C activation. TRPC5-transfected cells were pre-incubated for 30-60 minutes with 5 μM of 
the PLC inhibitor U-73122 or the inactive analog U-73343. Thereafter cells were probed with 
210 mOsm extracellular solution and 10 μM carbachol (Cch). (A) I–V relationship of TRPC5 
current evoked by hypoosmotic solution and 10 μM carbachol (Cch) in the presence of 5 μM 
U-73122. (B) Effect of U-73122 and U-73343 on percentage of responsive cells to 
hypoosmotical stimulus and Cch compared to untreated TRPC5(+) cells obtained from the 
type of recordings shown in (A). **, P < 0.01, compared with non-treated cells and #, P < 
0.05 compared with U-73343 treated cells (Z-test; n ≥ 6 patches for each condition). (C) Bar 
histogram summarizing the effects of U-73122 and U-73343 on TRPC5 currents induced by 
hypoosmotic solution and 10 μM Cch. Mean values were measured in > 6 cells for each 
experimental condition (*P < 0.05, the (*) denotes statistical significance between cells 
treated with U-73122 and untreated cells and (#) between cells treated with U-73343 and 
untreated cells; One way ANOVA). (D) Cytosolic Ca2+ signals from cells transfected with 
TRPC5 in response to 210 mOsm solution in the presence of ACA. (E) Whole-cell current 
obtained from ± 100 mV voltage ramps in a cell expressing the TRPC5 channel during the 
exposure of 210 mOsm solution in the presence of ACA. Note the current activation by ACA. 
(F) I–V relationship measured at maximal current from the same cell as E (colour dots) during 
the different experimental conditions (n = 4 patches). 
 
Fig. 6. TRPC5 activation is strongly impaired in PIP2-depleted cells. Time course of 
whole-cell currents in cells expressing TRPC5 channels during exposure to 210 mOsm 
solution and 500 μM ATP in a non-treated (A) and a tetracycline-treated cell (C). (B,D) I–V 
relationship measured at maximal current (colour dots) from the same cells as A and C 
respectively. (E) I–V relationship of the current evoked by hypoosmotic stimulation and 500 
μM ATP in a tet-treated cell recorded with 10 μM diC8PI(4,5)P2 in the patch pipette (n=10). 
(F) Bar histogram summarising the results obtained in experiment shown in A-E. ***, P < 
0.001 significance for tet-treated cells versus non-treated cells and #, P < 0.05 significance for 
tet-treated cells versus tet-treated cell recorded with 10 μM diC8PI(4,5)P2 in the patch pipette 
(Z-test). (G) Mean evoked current increment at -80 and +80 mV activated by hypoosmotical 
solution and ATP in the same conditions than Fig. F. *, # P < 0.05 significance for non-treated 
cells versus tet-treated cells and non-treated cells versus tet-treated cell recorded with 10 μM 
diC8PI(4,5)P2 in the patch pipette respectively (One way ANOVA). *** P< 0.001 
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significance for tet-treated cells versus non-treated cells (Student’s t-test). (H-I) 
Representative [Ca2+]i signals obtained in non-treated and tet-treated cells transfected with 
TRPC5 in response to 210 mOsm solution and 500 μM ATP. (J) Bar histogram summarizing 
the effect of PIP2 depletion from type experiments shown in H-I. *** denotes the P < 0.001 
significance (Z-test) for the hypoosmotic and ATP responses for non-treated (3 independent 
experiments) versus tet-treated cells (5 independent experiments). The number of the 
analyzed cells is indicated above each column. 
 
 
Fig. 7. Pressure-induced stretch activation of TRPC5 channels.  
(A) Representative time course of whole-cell current development induced by steps of 
positive pressure applied to the interior of HEK293 cell transfected with TRPC5. (B) I–V 
relationship obtained at maximal current from the same cell as in (A) (colour dots). (C) Mean 
evoked current increase to positive pressure (n = 19 patches). (D) Time course of whole-cell 
current in TRPC5-transfected cell induced by hypoosmotic solution and positive pressure. (E) 
I–V relationship obtained at maximal current from the same cell as in (D) (colour dots). Note 
the very similar shape of the I-V relationship in response to both stimuli. The applied pressure 
is indicated at the lower panel in A and D ranging from 10 to 50 mmHg. (E) Representative 
time course of whole-cell current development induced by steps of positive pressure applied 
to the interior of HEK293 cell transfected with the empty vector pCI-NEO. 
 
Fig. 8. Expression of TRPC5 channels in primary sensory neurones. (A) RNA from 
trigeminal and dorsal root ganglia, hippocampus and HEK-293 cells was reverse transcribed 
(+) and PCR amplified with specific primers for murine and human TRPC5. The (-) symbols 
in the panels indicate the reactions for each RNA sample run in the absence of SuperScript II 
(see Methods). Water lines correspond to the PCR mix with water as a negative control for 
PCR amplification. 
(B-E) Immunocytochemical staining of TRPC5 in dissociated mouse TG neurones visible in 
transmitted (B) and confocal microscopy (C) and for the secondary antibody visible in 
transmitted (D) and confocal microscopy (E). Anti-TRPC5 immunoreactivity is indicated in 
red and Hoechst nuclear staining in blue. TRPC5-positive neurones are indicated by arrows 
and -negative by arrowheads. Scale bar 10 μm. (F) Histogram of TG cell size distribution of 
TRPC5-immunoreactive cells. 
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